Health Condition 1: null- Any short elective surgical procedure under general anaesthesia which can be performed with LMA insertion
Conditions
Interventions
Intervention1: Group M received 0.5 mg/Kg oral midazolam and intranasal saline, group D received 2µg/Kg intranasal dexmedetomidine along with oral honey 20-30min before procedure.: EC 50 for LMA ins
Sponsors
Post Graduate Institute of Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2 patients of either gender of the age 1- 6 years undergoing any short elective surgical procedure under general anaesthesia which can be performed with LMA insertion
Exclusion criteria
Exclusion criteria: airway malformations, clinical evidence of patients with difficult airway, asthma or any sign of upper respiratory tract infection, G6PD deficiency, organ dysfunction , allergy or hypersensitive reaction to dexmedetomidine , known cardiac arrhythmia or congenital heart disease, mentally disabled , known case of autism or developmental pervasive disorder or failure to insert LMA.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine and compare the EC50 of sevoflurane for LMA insertion in children in all the three groupsTimepoint: At or one minute after LMA insertion | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay Sedation Score, parental separation score, induction score success rate, and the incidence of adverse eventsTimepoint: Ramsay sedation score at baseline, 15 and 30 minutes after premedication, parental separation score at taking the child in the OT and induction score at placing the face mask, adverse events at or one minute after LMA insretion | — |
Countries
India
Contacts
Public ContactDr Babita Ghai
Post Graduate Institute of Medical Education and Research, Chandigarh
Outcome results
None listed